ong-Term Evaluation of a Hearing Aid Supported Tinnitus Treatment utilizing Notch Filtering at the Tinnitus Frequency

Phase 2

• Conditions: H93.1; Tinnitus

• Registration Number: DRKS00011005
• Lead Sponsor: MediClin Bosenberg Kliniken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-11-15
• Study Start: 2016-12-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Chronic (>6 months), tonal Tinnitus with a TQ12 score of more than 10 without temporal interruptions.

Mild to moderate hearing loss.

No history of neurological diseases.

Exclusion Criteria

Alzheimer's disease, Meniere syndrome, acusticus neurinom or psychopathologies such as attention deficit disorder.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tinnitus questionnaires TQ52 (Goebel and Hiller). We evaluated the TQ52 scores for six months post-intervention period. TQs were evaluated after three and six months respectively

Secondary Outcome Measures

Name	Time	Method
Evaluation of electroencephalographic data (wavelet phase stability as habituation measure). We utilized ramped pure tone bursts (40ms) in the individual tinnitus frequency at MCL. Evaluation of 600 single sweeps